MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Genetic determinants of early motor progression in Parkinson’s cohorts

    A. Martinez-Carrasco, M. Lawton, R. Real, M. Tan, C. Carroll, JC. Corvol, D. Grosset, M. Hu, J. Hardy, N. Williams, Y. Ben-Shlomo, M. Shoai, H. Morris (London, United Kingdom)

    Objective: To determine the genetic determinants of motor progression in Parkinson disease (PD) using genome-wide analysis correlated with the MDS-UPDRS Part III motor scale. Background:…
  • 2022 International Congress

    Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson’s disease

    M. Dileone, C. Ammann, V. Catanzaro, C. Pagge, R. Piredda, MHG. Monje, I. Navalpotro-Gómez, A. Bergareche, MC. Rodriguez-Oroz, L. Vela, F. Alonso-Frech, MJ. Catalán-Alonso, JA. Molina, N. López-Ariztegui, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To investigate the potential of transcranial static magnetic field stimulation (tSMS) as a non-pharmacological, non-invasive, home-based treatment to manage levodopa-induced dyskinesias (LIDs) in Parkinson’s…
  • 2022 International Congress

    Social cognition and emotional processing in functional movement disorders

    A. Tomic, I. Petrovic, M. Jecmenica Lukic, N. Dragasevic Miskovic, N. Kresojevic, V. Markovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: Our objective was to assess the social cognition (Theory of Mind) and emotional processing (alexithymia) in patients with functional movement disorders (FMD). Background: The…
  • 2022 International Congress

    The anti-alpha-synuclein antibody Lu AF82422 was safe and well tolerated in a FIH-SAD study in healthy subjects and patients with PD

    L. Buur, J. Wiedemann, F. Larsen, F. Ben Alaya-Fourati, P. Kallunki, D. Ditlevsen, M. Sørensen, D. Meulien (Valby, Denmark)

    Objective: Evaluation of safety, tolerability, pharmacokinetics (PK) and target engagement (TE) in healthy subjects (HS) and patients with Parkinson’s disease (PD) following single ascending doses…
  • 2022 International Congress

    The role of intraoperative electrophysiological monitoring in implanting globus pallidus internus electrodes in patients with dystonia

    J. Kunst, D. Hrabovsky, T. Jurkova, J. Chrastina, M. Balaz (Brno, Czech Republic)

    Objective: The first aim was to compare the preplanned GPi electrode neuroradiological trajectory with the final trajectory selected after electrophysiological monitoring. The second aim was…
  • 2022 International Congress

    Pooled safety analysis of incobotulinumtoxinA in the treatment of neurological disorders in adults

    C. Comella, M. Hast, A. Hanschmann (Chicago, USA)

    Objective: To examine the pooled incidence of treatment-emergent adverse events (TEAEs) and immunogenicity by indication in sponsored incobotulinumtoxinA (INCO) clinical trials in adults. Background: The…
  • 2022 International Congress

    Emotion Recognition in Multiple System Atrophy – an Eye-Tracking Study

    V. Sidoroff, F. Carbone, P. Ellmerer, S. Bair, A. Hoffmann, T. Maran, C. Raccagni, K. Seppi, G. Wenning, A. Djamshidian-Tehrani (6020, Austria)

    Objective: To get better insights into emotion processing in patients with MSA-P compared to healthy controls (HCs) by using two different Eye-Tracking paradigms. Background: MSA…
  • 2022 International Congress

    Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections

    J. Jacinto (Alcabideche, Portugal)

    Objective: To present an experts’ consensus on the use of botulinum neurotoxin (BoNT) injections in the multi-pattern treatment of shoulder spasticity to increase awareness of…
  • 2022 International Congress

    A double-blind randomized clinical trial to evaluate the effects of Candesartan for Cognitive and Neuropsychiatric Impairment in Parkinson’s Disease

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Puig-Davi, J. Pagonabarraga, J. Rodriguez-Antiguedad (Barcelona, Spain)

    Objective: To explore the feasibility of repurposing candesartan for the treatment of cognitive impairment and neuropsychiatric symptoms in PD. Background: There is an urgent need…
  • 2022 International Congress

    Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

    A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This cross-sectional study investigated the relationship between depression and sigma absolute spectral power (9-15 Hz) in the frequency range of sleep spindles during non-rapid…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley